| ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
|---|---|---|---|---|---|---|
| C566443635566190423 |
|
240417-00-9 |
2-(Diphenylphosphino)-2′-(N,N-dimethylamino)biphenyl - 98% |
0 | C26H24NP | |
| C566443635566190422 |
|
87-63-8 |
2-Chloro-6-methylaniline - 99% |
0 | C7H8ClN | |
| C566443635566190421 |
|
71989-20-3 |
Nalpha-FMOC-L-Glutamine - 98% |
0 | C20H20N2O5 | |
| C56644363556619043 |
|
609-06-3 |
L-XYLOSE - 98% |
0 | C5H10O5 | |
| C56644363556619042 |
|
29166-72-1 |
2-TERT-BUTYL-1,1,3,3-TETRAMETHYLGUANIDINE - 97% |
0 | C9H21N3 | |
| C56644363556619041 |
|
1355357-49-1 |
Remdesivir impurity2 - 98% |
0 | C33H31N5O4 | |
| C56644363 |
|
1075-49-6 |
4-Vinylbenzoic acid - 98% |
0 | C9H8O2 | |
| C56644363478 |
|
— |
SparfloxacinLactate - 98% |
0 | C19H22F2N4O3·C3H6O3 | |
| C5664436355661904 |
|
18741-85-0 |
(R)-(+)-2,2'-Diamino-1,1'-binaphthalene - 98% |
0 | C20H16N2 | |
| C5664436355661903 |
|
16037-91-5 |
Sodium Stibogluconate - 98% |
0 | C12H37Na3O27Sb2 | |
| C56644363556619021 |
|
193149-74-5 |
WST-8 - 99% |
0 | C20H15N6NaO11S2 | |
| C5664436355661902 |
|
180288-69-1 |
Trastuzumab - 98% |
0 | — | |
| C5664436355661901 |
|
19798-81-3 |
2-Amino-6-bromopyridine - 98% |
0 | C5H5BrN2 | |
| C566443635566189 |
|
90213-66-4 |
2,4-DICHLORO-7H-PYRROLO2,3-DPYRIMIDINE - 98% |
0 | C6H3Cl2N3 | |
| C5664436355661851311 |
|
831-61-8 |
Ethyl gallate - 99% |
0 | C9H10O5 | |
| C56644363556618513 |
|
1445085-77-7 |
RuPhos Pd G3 - 98% |
0 | C43H57NO5PPdS- | |
| C56644363556618512 |
|
479094-62-7 |
DI-TERT-BUTYLMETHYLPHOSPHONIUM TETRAFLUOROBORATE - 98% |
0 | C9H22BF4P | |
| C56644336 |
|
178601-88-2 |
(Z)-Cefdinir - 95% |
0 | C14H13N5O5S2 | |
| C56644335 |
|
943609-66-3 |
Vedolizumab - 98% |
0 | — | |
| C566443635566185 |
|
697739-03-0 |
Methyl 5-fluoro-2-methyl-3-nitrobenzoate - 98% |
0 | C9H8FNO4 | |
